IL1B and arthritic joint disease: This finding is in concordance with studies in arthritis, where miR-155-5p drives inflammatory activation of macrophages and monocytes by targeting inhibitors of TLR and cytokine receptor pathways, thus resulting in increased production of the cytokines TNF, IL-6, IL-8, and IL-1β [64–66].